British Journal of Anaesthesia, Vol 75, Issue 4 462-466, Copyright © 1995 by The Board of Management and Trustees of the British Journal of Anaesthesia
T. L. Chen, M. J. Wang, C. H. Huang, C. C. Liu and T. H. Ueng
We have compared the in vivo and in vitro effects of propofol on cytochrome
P450-dependent monooxygenase activities in hamster liver microsomes.
Propofol (Diprivan) 10 mg/100 g body weight was injected i.p. twice a day
for 2 weeks to induce cytochrome P450 enzymes. Liver microsomes were
prepared by differential centrifugation. Metabolism of the cytochrome
P450-dependent mono-oxygenase system was evaluated by measuring aniline
hydroxylation, benzphetamine demethylation and benzo(a)pyrene
hydroxylation. Defluorination of enflurane was assayed by detecting free
fluoride metabolites. At similar concentrations as in the in vivo group,
propofol in vitro exhibited concentration-dependent inhibition of
metabolism of benzphetamine and benzo(a)pyrene. Aniline hydroxylation and
defluorination of enflurane were inhibited to 78% of control with propofol
0.25 mmol litre-1. In propofol-treated hamsters, there was only minimal
inhibitory or inductive effects on either mono- oxygenase activities or
capacity for defluorination. This difference between the in vitro and in
vivo effects of propofol on cytochrome P450 mono-oxygenase activities
emphasizes the need for care when comparing in vitro and clinical data.
LABORATORY INVESTIGATIONS
Difference between in vivo and in vitro effects of propofol on defluorination and metabolic activities of hamster hepatic cytochrome P450-dependent mono-oxygenases
Department of Anaesthesia, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan 100, Republic of China; Institute of Taxicology, College of Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan 100, Republic of China
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Wandel, R. H. Böcker, H. Böhrer, J. X. deVries, W. Hofmann, K. Walter, B. Kleingeist, S. Neff, R. Ding, I. Walter-Sack, et al. Relationship between Hepatic Cytochrome P450 3A Content and Activity and the Disposition of Midazolam Administered Orally Drug Metab. Dispos., February 1, 1998; 26(2): 110 - 114. [Abstract] [Full Text] |
||||
